ONCONASE
Dead / Cancelled — Cancelled — Section 8 (as of 28 Jan 2022)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 74036571
- Registration number
- 1651885
- Mark type
- Word mark
- Filed
- 09 Mar 1990
- Published for opposition
- 25 Sept 1990
- Registered
- 23 Jul 1991
- Current term from
- 23 Jul 2011
- Attorney of record
- LAWRENCE E ABELMAN
Goods and services
- Class 005 — Pharmaceuticals: pharmaceuticals; namely, cancer-treating drugs
Owner
- TAMIR BIOTECHNOLOGY, INC., MONMOUTH JUNCTION, NJ, US
- Alfacell Corporation, Bloomfield, NJ, US
- Alfacell Corporation, Bloomfield, NJ, US
- Alfacell Corporation, Bloomfield, NJ, US
Board proceedings on this mark
The owner also pleads this mark in 1 other Board proceeding.
Board decisions about this mark
Prosecution history
- 28 Jan 2022 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 13 Aug 2011 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 13 Aug 2011 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 13 Aug 2011 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 27 Jul 2011 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 18 Jul 2011 — TEAS SECTION 8 & 9 RECEIVED
- 08 Nov 2007 — CASE FILE IN TICRS
- 01 Sept 2006 — REVIEW OF CORRESPONDENCE COMPLETE
- 21 Aug 2006 — PAPER RECEIVED
- 22 Aug 2001 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 22 Aug 2001 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 31 May 2001 — REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
- 01 Nov 1996 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 09 Sept 1996 — REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
- 23 Jul 1991 — REGISTERED-PRINCIPAL REGISTER